Overview

A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults

Status:
Completed

Trial end date:
2020-02-10

Target enrollment:

Participant gender:

Summary

This study will assess the safety and tolerability of multiple doses of BMS-963272 in obese but otherwise healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb